Feedback
Regulation Kurt
3H-chenodeoxycholic to
seven
whom patients the
acid was
regular
given
type.
when
ministered
acid for 3 wk.
given
“C-cholic
This
had
read-
treatment
with
cholic
control
times
concentrations
T
and
MAIN
HE
BILE
intestine.
teinemia corded
in most
teinetnia).
This
The
negative cholic-acid
with
discrepancy that appear
as bile
acids
these processes. feedback
of the
in
man
achieved
triggered
by the
on the aver-
concluded by
a
that
feedback
administration
are the two in addition
of
demonstrated
that
is associated whereas
bile
acids,
of cholic
bile
acid in
hyperpre-$-lipopro-
by an abnormally
reversed
hyper-@-lipoproteinemia
was mainly
primary
to the secondary
dehydroxylation
acids, ‘z’
of bile
patients
observation
regulating
by bacterial
studies
was
It was
findings
(type
due to differences
II
high
were
rc-
hyperlipopro-
in the pool
and turn-
acid.’
observed
cholesterol
bile acid,
hyperlipgproteinemia)
and production
over of cholic monly
IV
in all subjects 50%.
The
of
in human
formed
acid.
of chenodeoxycholic
cholic acid.
2-5
acid and cholic
acid.
Recent
(type
pool size
aim
ACIDS
chenodeoxycholic
acid. deoxycholic
the
the
effect
in comparison
chenodeoxycholic
age by about this
acid became
of
acid decreased
cholic
acid, the pool size of this enlarged,
that
acid in duode-
markedly
pool size and turnover
of
was
g nonradioactive
During
with
The
been
Kallner
nal bile increased
of
diet
and Mora
in Man
cholic acid and deoxycholic
orally
acid.
procedure
subjects
Hellstt%m,
five
a standardized
the
0.5-l
Kjell
subjects,
received
were
peated
Einarsson,
normolipemic
also
of Bile Acid Formation
present
the
two
types
to differ
with
stimulates Since
mechanism.
of
hyperlipoproteinaemia
regard further
investigations
the bile acid synthesis it appears
of interest
was
determine
investigation
feeding on the formation
to
mo\t
to the quantitative of
com-
elimination the
may be controlled to study the
of chenodeoxycholic
this
possible
ol
mechanisms process.
b! ;I The
influence
ot
acid in normolipemic
subjects. MATERIALS
AND
METHODS
t’utieut.\
Metabolism.
Vol. 22, No. 12 (December),
1973
1477
1478
EINARSSON,
Table
VA
Sex
Age Vd
M
48
HELLSTRijM,
AND
KALLNER
1. The Patients
Cholesterol*
Triglycerides*
(mg/lOO
(mg/lOO
ml)
230
ml)
150
Previous History and Present Symptoms
Myocardial Chronic
infarction cholecystitis
SH
M
66
280
140
Myocardial
infarction
KJ
M
55
290
152
Myocardial
infarction
GN
M
57
250
180
Angina
so
M
46
210
140
Partial
BA
F
67
265
190
Parathyroidectomy
II
F
63
245
180
Diabetes
pectoris thyroidectomy
Nephrolithiosis
(Adenoma)
Normal
range
*Means
of several
Experimental
140-285
80-
mellitus
180
determinations.
Procedure
The bile acid turnover was determined before and during treatment with cholic acid. The patients were hospitalized for 3-4 days before each study. They were fed 1700~1800 kcal/day of the regular hospital diet in which 35”,,, 20”,*, and 45”,, of the calories were supplied as fat. protein, and carbohydrate. respectively. The daily intake of cholesterol was about 300 mg. Before the second study. the patients received 0.5 g cholic acid during 2 wk and then a daily dose of 1 g of the acid for about 7 days. This treatment was not associated with any gastrointestinal complaints. ‘H-chenodeoxycholic acid (17-42 +Ci) in most of the experiments in addition to “C-cholic acid (4.0-7.5 KCi) as sodium salts were dissolved in water and administered orally in the morning to the subjects who fasted overnight. At 2 4 days interval, four samples of duodenal bile were collected from all subjects. Cholecystokinin was administered on each occasion, and approximately IO ml of concentrated bile was obtained through a thin polyvinyl tube. The specific radioactivity of administered bile acids was determined in each sample.
Materials Randomly tritium-labeled chenodeoxycholic acid (40 pCi/mg) was a gift from Dr H. Danielsson. purified by various chromatographic Stockholm. It was prepared by the method of Wilzbach,‘s procedures. and recrystalized to a constant specific radioactivity. Cholic acid-24-C” (I 3X pCi/mg) was purchased from New England Nuclear Corp.. Boston, Mass. The radiopurity was ascertained by autoradiography of thin-layer chromatograms. Unlabeled cholic acid u’as manufactured by Sigma Chemical Company, St. Louis, MO.. and administered to the patients in IOO-mg capsules.
The methods used for determinations of blood lipids and for puritication of dihydroxycholanic fractions of duodenal bile were performed as described acids were finally analyzed with gas-liquid chromatography after being treated and trifluroacetic anhydride. The half-life, pool size, and turnover of the termined as described by Lindstedt.’
the trihydroxyand recently.* The bile with diazo-methane bile acids were de-
RESULTS Most analyses of cholesterol and triglycerides in serum demonstrated normal values (Table I). Subject BA was considered normolipemic, although the triglyceride level was somewhat elevated in the first specimen obtained. The pattern of distribution of the serum lipoproteins was within normal limits in all subjects as evidenced by electrophoresis on agarose gel.
REGULATION
OF
BILE ACID
Table
FORMATION
2.
Turnover
1479
of Chenodeoxycholic
Chenodeoxychollc
Acid
and
Cholic
Acid Choltc
Acid
Acid
Cholzc Actd Half-Life
istered
(days1
fmgl
(mgiday)
2.6
521
139
1.6
874
VA +
SH +
BA
LSD
TurW3”el (mg
(mgi
i .a
316
122
1 .o
1431
1.9
869
322
1 .o
617
3.1
363
81
19941‘ 428
[ 1626)
2146
0.9
day
383
820
142
1.4
208
104
_
3.2
768
167
2.4
953
275
3.1
559
124
1.5
2770
(1259)
i .a
969
374
1.2
130
75
_
2.4
454
130
2.5
954
265
+
2.8
174
44
1.4
2995
(1513)
2.5
300
85
i .a
498
192
f
2.8
99
25
1.3
262 1
(1402)
II
M‘Xlll
Half-L,fe
4.0
_
SO
Turnover
+
KJ
GN
Pool S,ze
Pool S,re
Admin-
_
2.6
F 0.8
672
k 247
194
+
2.3
I~ 0.8
264
+ 161
82
7 109
1.8 f 0.6
t
I .2
38
i
0.3
779
+ 209
308
2393
r 621
(1358
95
I
245)
Significance
of differences *Values
within
NS parentheses
p c 0.005
do not represent
p c
endogenous
0.025
NS
p
0.001
(p
0.001)
synthesis.
Before the administration of cholic acid the half-life, pool size, and turnover of chenodeoxycholic acid varied between 1.2 4.0 days, 300 969 mg, and 85 373 mg/day, respectively. The corresponding values recorded for cholic acid in the five patients studied were 0.9-~2.5 days, 498 -953 mg, and 192 428 mg/day (Table 2). When the patients were reexamined during treatment with cholic acid, the serum lipids were found to be essentially unchanged. The therapy had no cvnsistent effect on the half-life of chenodeoxycholic acid. The size of the chenodeoxycholic acid pool decreased in all subjects. The mean value (259 * 16X mg) was less than half of that (672 * 247 mg) obtained previously (p Y 0.005). The turnover of chenodeoxycholic acid changed from 194 L 100 to 81 3 40 mg/day (p < 0.025). The administration of I g of cholic acid per day resulted in a considerable enlargement of the cholic acid pool which in the live patients studied ranged between 1431 and 2995 (mean 2393) mg. The total bile acid pool was most probably much higher since the concentration of deoxycholic acid in the bile increased markedly in relation to that of chenodeoxycholic acid (Table 3 and Figs. I and 2). In several patients the bile contained more deoxycholic acid than cholic acid (Table 3). The half-life of the latter acid tended to incrcasr, but this eiIect was not statistically significant. DISCUSSION Much knowledge concerning the mechanisms regulating the formation of hilt acids in vivo are based on studies with experimental animals. In rats with bile duct fistulas Shefer et al.6 confirmed previous observations by Bergstrom and
1480
EINARSSON,
fable
3.
Mean
Ratio
Between
Duodenal
Bile
HELLSTROM,
Cholic
(C),
Chenodeoxycholic
(CD)
and
Before
and
During
With
Cholic
Chok Patient
Treatment
SH
GN BA
II Meall
Deoxycholic
KALLNER
Acid(D)
in
Acid
Acid
Admlnnrtered
VA
AND
C CD
D
_
0.9:
+
2.5i li 3.4
_
2.5;
+
5.11 II 11.2
1: 0.7
i
1 1.2
_
1.51 110.2
+
3.21 II 3.3
_
1.01 II 1.2
+
6.21 li 7.0
_
1.51 li 3.5
+
18.3; li 11.4
_
1.5 10.6i
+
7.1 1k6.51 li 7.3 f
1; 1.4 11.2 3.9
Significance
NS
of differences
D < 0.02
Danielsson7 that intraduodenal infusion of bile acids resulted in synthesis of such compounds in the liver. In other studies Danielsson Shefer et al? presented evidence that the rate-limiting step in the bile acid is the conversion of cholesterol to 7a-hydroxycholesterol. In an intact animal most of the bile acids excreted with the bile to the liver with the portal vein blood. To maintain a steady-state the liver has to produce enough bile salts to replace the fecal loss.
an inhibited et al.” and synthesis of are returned condition A feedback
RATIOS BETWEEN BILE ACIDS D :CO: C 431: 1 :&S4
I
CD
10 Fig. acid.
1.
GLC
20
of a specimen
D; deoxycholic
acid;
CD,
of duodenal
30 bile
chenodeoxycholic
40
50
(subject
VA)
obtained
acid;
C, cholic
acid.
before
MIW treatment
60 with
cholic
REGULATION
1481
OF BILE ACID FORMATION
RA1l.S BETWEEII DIM ACIDS D IeD: c 2.3: 1 : 2,4
Fig. acid.
2.
GLC
of a specimen
D, deoxycholic
control
acid;
of this
i.e.,
bile acid pool. uith
whereby
was
(subject
VA)
obtained
acid;
C, cholic
acid.
should
be triggered
by the rate (number)
These
cannulae
bile
chenodeoxycholic
synthesis
ing the liver,
the bile
of duodenal
CD,
phenomena
in the common collected
for
studied
bile duct and the duodenum.‘0
A given
circulation The
synthesis
at maximum
up to 7 mmole/24
The
evidence of a feedback
resection
hr
diversion
individual
tions The helng
animals.
trczted
The
in an intact
of individual
participating with
cholic
results
were
oral
being.‘3,‘3
and
at
also
of the inflow
after
of ex-
of bile
in a way similar
to
the ratios
be-
of cholic
and
the hepatic
quantitative
I2
by ileal
by a stimulation
suppress
At
in man is
circulation
administration
However.
had
proceeded
to the liver.
by measuring
01
intestine
animals
decrease,
encountered
a reduction
obtained
after
bile
determina-
bile acids were not performed.
in the present acid they
returned
bile salt
that these compounds
human
The
of the
portion
the
compounds
is followed
effects that
intact.
the bile acid formation
in the bile
acid indicate
of rhc formation patients
stimulates
bile acids
chcnodeoxycholic acid synthesis
similar
to
to
cholic
provided
the bile acid synthesis
of cholestyraminc
Since
liver
that in experimental turcn
regulating
of the bile, ” it appears
acids to the human
were began
of the enterohepatic
or by administration
the bile acid formation.” ternal
control
An interruption
returned
of such
was
was kept almost
I mmnle.
when
circulations monkeys
and the rest
with
of bile acids rexn-
in Rhesus
a bile acid pool of about rates
by the amount
treatment
of the enterohepatic
were
analysis
the enterohepatic
during
study
had a pool
were all normolipemic. Ge
and turnover
Before
of chenode-
1482
EINARSSON,
HELLSTROM,
AND KALLNER
oxycholic acid that averaged 672 mg and 194 mg/day, respectively. Vlahcevic et al.” administered r4C-labeled chenodeoxycholic acid to healthy subjects and the mean pool size and turnover were found to be 810 mg and 162 mg/day, respectively. The close agreement between these results indicates that the possible errors caused by instability of the 3H-labeled chenodeoxycholic acid used in the present study were of minor importance. The values recorded for cholic acid also corresponded with previous observations in healthy subjects fed a natural diet.5,‘5s’6 The ratio between cholic acid, chenodeoxycholic acid, and deoxycholic acid in duodenal bile was in general within the range observed in healthy Swedish students.17 The daily dose of cholic acid prescribed in this study (I g) exceeded the pretreatment values of the cholic acid pools sizes by 50&500 mg. As a result of the treatment this pool was enlarged 2-5 times. Part of the cholic acid administered appeared to be transformed into deoxycholic acid as the concentrations of these two acids in duodenal bile increased relative to that of chenodeoxycholic acid. The sizes of the deoxycholic acid pool were estimated indirectly from the corresponding values recorded for the primary bile acids and the mean proportion between the individual bile acids in duodenal bile. Since these ratios showed some day-to-day variations, the values obtained were approximate. They indicated that the sizes of the combined pools of cholic acid and deoxycholic acid averaged about 1500 mg before and 4900 mg during the administration of cholic acid. The values obtained for the pool size and the turnover of chenodeoxycholic acid decreased upon treatment with cholic acid. For both parameters the changes averaged 50”,,. There was no diarrhea or other signs of general malabsorption, and it appeared that the altered kinetics of chenodeoxycholic acid was due to a hepatic effect (feedback inhibition) triggered by the administration ot cholic acid. A question of importance not settled by this investigation is whether cholic acid feeding influenced the formation of cholic acid itself. In four out of five patients the “turnover” of cholic acid calculated during the treatment period exceeded or equaled the combined amount administered during the second and synthesized during the first investigation. This finding, which appears to give a negative answer to the question raised above, could have other explanations. It may reflect that the cholic acid turnover had not reached a steady state during the period when the patients were fed the acid. Furthermore, a slight reduction of absorption of cholic acid in the intestine and thus also of the isotope administered could result in an overestimation of the pool sire and consequently of If so, we may also overestimate the synthesis of chenodethe “turnover.” oxycholic acid and thus underestimate the feedback inhibition. The main findings of this study demonstrated that oral administration of one of the primary bile acids influenced the formation of the other one probably by a negative feedback control. Hyperlipoproteinaemia type I1 is associated with a subnormal and hyperlipoproteinaemia type IV with an elevated bile acid synthesis. Whether these abnormalities are related to abnormalities in the hepatic feedback control will be the subject of further investigations.
REGULATION
1483
OF BILE ACID FORMATION
REFERENCES I,
Kottkc
crctlon.
BA:
Din‘erenca
Primary
in
bile acid ex-
hypercholrsterolaznli~
com-
pared to combined hypercholesterolacmla h~p~rtrlfl\i~eridemia. 7
Einarsvn
Circulation
I(. Hellstriim
h!pcrlipopr~>teinacmia.
with
formatton
three
Eur J Clin
type\ of
Invest
2:225.
3. Wollrnsrber
J. Stiehl A: (;riihst:
und Turnover
dcr primiren
tc~nlimle. Kiln 4, Sjiivall
II
Wochenwhr
bei
50:?3.
1972
bile acids in man: Comparative tyramine and ileal exclusion
Acta
Turnover
S. Hauscr
12. Samuel
P.
EH.
(‘hem
Sand
Ci:
In01.
elect.\ ol’chole\-
on cholesterol
Saypol
CiM.
ChJfi/adeh
me-
M:
Meilman
t_.
.i\brorptlon
01
In
J <‘lln
IY6X
13. Thl$tle
of chullc
acid 111
JL.
Schoenfirld
composition
LJ:
of
Induced
bile
.!I-
01 person\
hactng chc)lelithla\l\. C;astrocnterol~>g!
S, Brhersk)
t-ccdhack regulation
I. Moshach
01‘ bile acld blo\yn-
S. DanIelson
11: On the reg-
ulatlon 01’ bllc acid lormation
In rhc rat lI\,cr.
Acta Phqblol Sand
-13: I
1958
H. Elnarswn
Ell’cct ~1‘ billclrk
I(. Johanson
dralnctge on individual
tlon\ 111the conversion
01‘ cholesterol
chollc ~tcld. t-ur J Biochcm 2:lj. L11, BlochcmIcaI
bitt 01‘ regulation
hio\! nthehl\ In the rat. J Lipid RH.
fwt\ ~1‘ controlled hrpatlc clrcuI:It1on
Mack
to tauro-
I. Moshach of bllc .icid
Rc\ I 1:40-I.
E. Small
interruption
(;: reac-
lY67
Y. Shcl’cr S. Hauacr S. Beker\hy
IJ.
Danongcr
LJ. Thlhtlc
thesls 1n the rat. J L.lpid Rr\ IO:hJb. IYhY
Doullnp
Salen
arculatlon
J Lab Clin Mcd 7X:93. 1971
Moshach
tcratlon\
J
flI:ISX.
lY71
[Llndhtcdt S:
S. D,~nicl\wn
LH.
Inbest 37:2070.
m.tr~. Act;! Ph\\iol Stand JO: I. 1957
7. Berg\triim
Ahrenc
bile acids l’rom the large bowel in man
Hyperhpopro-
lh 1761. I’)62
h. Shelrr
SM.
of the cnterohrpatlc
IV
analy\ih or bile acid\
b\ $a\ chr
IO
Cirundy
terruption
monkev.
1970
lJntcr\chiedllchc und T>p
J: Qualitative
de\ Pools
Ciallen\Llurrn
H!perlIpopr~)t~in;imlrn: Belunde bet Typ
EH:
snd pool size in the Rhesus
tabolism.
I’)73
i
synthesis
Clin Invest 49232. II.
40: 13. I969
K: The
01 bile acids in patlents
and
sion and by ileal resectlon on bile salt \ecretltjn.
DM:
of bile salt\ b> hlllar!,
Schocnllcld
of cholesterol
g:lll-
2x6: I. lY72 Ii. Shell
Vlahcev~c LR, L: Kinetlo
Miller
JR,
Ih.
Hcll\trtim
t’ormatlon
of
standardwed Sjdvall
chollc diet
acid
with
IS. pwurr
lr. hilt
lY7l
S: Studle\ on the in
huttcr
J: DIetar)
bile acid conjugation BIOI Mrd
61:X5.
I(. Lindstedt
dietarc 1.11.Am J C‘lin Nutr I7
Farrar
nnd pool \ize or prlmar?
acids In man. C;a\troenterolog
El-
diwr-
KC;. Hol’man At.. Disholution
stone:, b! chenodeo\ycholic acid. N E ngl J Mcd
1970
01 the entcro-
JI.:
\uh.jcct\ g~\cn or
IY:16,
corn
011 .I\
lY66
glhcine and taurlnc in man.
Proc
Sw
on t-\p
lOO:h76. lY5Y
Ull/bach
hl:.
Tritlum-lahelllng
t,f oreangc compound5
J Am (‘hem Sot 7Y~lOl?.
I’)17
h!
to tritium
c’\~:LI.